Genome-wide analysis demonstrated that SMOC2 was hypermethylated in over 70% of pancreatic cancers and less than 10% of normal pancreas17, and SMOC2 was one of the candidates for a “highly methylated” signature for endometrial cancers20. The gene discussed is SMOC2; the disease is pancreatic neoplasm.